GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr | ₹14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹-38 Cr |
Mar2024 | ₹389 Cr |
Mar2023 | ₹19 Cr |
Mar2022 | ₹255 Cr |
Mar2021 | ₹14 Cr |
How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹-38 Cr | Negative | |
Mar2024 | ₹389 Cr | 1,902.17 | |
Mar2023 | ₹19 Cr | -92.37 | |
Mar2022 | ₹255 Cr | 1,695.19 | |
Mar2021 | ₹14 Cr | - |
Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹56,174.7 Cr | 3.5% | -4% | 18.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,659.0 Cr | -0.7% | -3.6% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,886.0 Cr | 0.3% | -5.5% | 22.4% | Stock Analytics | |
CIPLA | ₹127,435.0 Cr | -0.8% | 4.1% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,719.0 Cr | 1.1% | -0.5% | 5.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,610.0 Cr | -0.8% | 2.3% | -8.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 3.5% |
-4% |
18.8% |
SENSEX | 0.8% |
0.2% |
-2% |
You may also like the below Video Courses